Bizarre Patents
An enclosure for small animals which is wearable on the front or back of an animate being.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 8008480 | Process for the purification of meloxicam A process for purifying meloxicam form I from a crude meloxicam, which comprises: i. contacting the crude meloxicam with an amine in a non-aqueous solvent to form a meloxicam salt; ii. isolating the meloxicam salt;... | 08/30/2011 |
| 7671197 | Process for the purification of meloxicam The present invention relates to a process for the purification of meloxicam and in particular of the impurity composed of 4-hydroxy-2-methyl-N-ethyl-N′-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide and to meloxicam containing a quantity of... | 03/02/2010 |
| 7419542 | 2,9-dichloro-quinacridone as α-quinacridone crystal phase inhibitor The invention is directed to a method or use of 2,9-dichloro-quinacridone as an alpha crystal phase inhibitor and optionally, 4,11-dichloroquinacridone during the beta-quinacridone or gamma-quinacridone crude pigment particle size reduction processes. The invention ... | 09/02/2008 |
| 7407950 | -(heteroaryl)-1-indole-2-carboxamide derivatives and their use as vanilloid TRPV1 receptor ligands The invention concerns compounds of general formula (I), wherein n, X1, X2, X3, X4, Z1, Z2, Z3, Z4, Z5 and W are as defined herein. | 08/05/2008 |
| 7375220 | Method of treating diseases and conditions associated with an altered level of amyloid β peptides and new enolcarboxamide compounds A method of treating or preventing of a disease or condition associated with an increased level of isoforms of amyloid β peptides (Aβ) and/or with a changed ratio of levels of Aβ isoforms and/or with the formation of plaques containing amyloid β peptide (Aβ) is... | 05/20/2008 |
| 7262190 | Benzothiazine and benzothiadiazine compounds The invention relates to compounds of formula (I): wherein: R1 represents hydrogen, alkyl or cycloalkyl, R2 represents hydrogen, halogen or hydroxy, A ... | 08/28/2007 |
| 7232826 | Tyrosine kinase inhibitors The present invention provides compounds of Formula I or II that are useful as anti-cancer agents and other diseases that can be treated by inhibiting tyrosine kinase enzymes ... | 06/19/2007 |
| 7199118 | Benzothiazine derivatives, their preparation and use This invention relates to novel benzothiazine derivatives of Formula I useful as modulators of the AMPA sensitive glutamate receptors, pharmaceutical compositions comprising such compounds and their use in therapy. ... | 04/03/2007 |
| 7101428 | 2,9-Dichloro-quinacridone as alpha-quinacridone crystal phase inhibitor The invention is directed to a method or use of 2,9-dichloro-quinacridone as a crystal phase inhibitor during the beta-quinacridone or gamma-quinacridone crude pigment particle size reduction processes. 2,9-dichloroquinacridone is added to the milling composition of... | 09/05/2006 |
| 6967248 | Crystalline forms of meloxicam and processes for their preparation and interconversion The invention relates to the new crystalline forms II, III and V of meloxicam; to the processes for obtaining the crystalline forms I, II, III and V; and, finally, to the interconversion processes of the forms II, III, IV and V into the form I. | 11/22/2005 |
| 6960579 | Serotonergic 5HTreceptor compounds for treating ocular and CNS disorders Compounds with 5HT7 receptor affinity (some of which are novel) useful for lowering IOP, improving blood flow to the optic nerve head and the retina, providing neuroprotection, and treating retinal diseases are disclosed. The Compounds are also useful for... | 11/01/2005 |
| 6894041 | Oxazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes This application is directed to compounds useful as inhibitors of PDE4 in the treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructuive pulmonary disease, of the formula: | 05/17/2005 |
| 6881840 | Benzothiazine dyes for imaging elements This relates to a dye represented by Formulae II and IIA below: wherein; R1 represents a hydrogen, an aryl group containing 6 to 14 carbon atoms, or an alkyl group containi... | 04/19/2005 |
| 6869945 | Pyrrolyl-and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes This application is directed to compounds useful as inhibitors of PDE4 in the treatment of diseases regulated by the activation and degranulation of eosinophils, especially asthma, chronic bronchitis, and chronic obstructuive pulmonary disease, of the formula: | 03/22/2005 |
| 6869974 | Pharmaceutical compounds Compounds or their salts having general formulas (I) and (II): wherein s is an integer equal to 1 or 2, A is the radical of a drug that satisfies certain pharmacological tests, C and C1 are bivalent radicals, and precursors of the radicals B and B1 | 03/22/2005 |
| 6869948 | Meloxicam for oral administration The invention relates in its first aspect to a rapidly decomposing tablet for pain therapy containing meloxicam [4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide] in the form of a salt with an inorganic or organic base provi... | 03/22/2005 |
| 6844338 | Piperidyindoles as serotonin receptor ligands A pharmaceutical compound of the formula (I) in which R1 and R2 are each hydrogen or C1-6 alkyl, R3 is —SR10, —SOR10, —SO2R10, —COR10, —CH2OH or â... | 01/18/2005 |
| 6759406 | Quaternary ammonium compounds Compounds of formula corresponding to either formula (Ia) or (Ib): wherein: M represents a molecule that can be used for the treatment or diagnosis of pathologies caused by attack on the cartilage, R1 | 07/06/2004 |
| 6713477 | Hydroxamic acid derivatives A hydroxamic acid derivative represented by formula (1) or a prodrug thereof, or a pharmaceutically acceptable salt thereof, which has a matrix metalo-proteinase inhibitor. ... | 03/30/2004 |
| 6683101 | Bicyclic cyclohexylamines and their use as NMDA receptor antagonists Described are heterocycle-substituted cyclohexylamines of formula (I), and their pharmaceutically acceptable salts thereof. The compounds of the formula (I) are antagonists of NMDA receptor channel complexes useful for treating cerebral vascular disorders... | 01/27/2004 |
| 6664251 | Benzothiazine derivative Disclosed are benzothiazine derivatives represented by the following formula (I): ##STR1## wherein the dashed line indicates the presence or absence of a bond; Z represents one of the following groups: ##STR2## in which R1 and R2 | 12/16/2003 |
| 6642383 | Oxopiperazinyl derivatives and light stabilized compositions Compounds of the formula (I) ##STR1## wherein p is zero or 1; q and r, independently of each other, are an integer from 1 to 6; and s is a number ranging from 1 to 8; X is --O-- or, when p is 1, X is also a group ##STR2## Rw, R | 11/04/2003 |
| 6559144 | Bicyclic amino acids Compounds of the formula I ##STR1## in which X, Y, Z, R1, R2, R3, R4, R5, R7, R8, R11, m and n have the meanings stated in claim 1, and their physiologically acceptabl... | 05/06/2003 |
| 6545150 | Certain benzothiazine dioxide endothelin antagonists and processes for their preparation The instant invention is a series of benzothiazine dioxides, or a pharmaceutically acceptable salt thereof, which are potent endothelin A antagonists with profound in vitro activity, and improved syntheses for the Formula 1 ##STR1## The compounds are... | 04/08/2003 |
| 6448241 | Thiazolobenzoheterocycles, their preparation and medicaments containing them Compounds of formula (I): ##STR1## their racemates, enantiomers, diastereoisomers and inorganic acid salts and organic acid salts thereof, processes for preparing them and the medicaments containing them are discussed.... | 09/10/2002 |
| 6440962 | Certain benzothiazine dioxide endothelin antagonists and processes for their preparation The instant invention is a series of benzothiazine dioxides, or a pharmaceutically acceptable salt thereof, which are potent endothelin A antagonists with profound in vitro activity, and improved syntheses for the Formula I ##STR1## The compounds are... | 08/27/2002 |
| 6436927 | IL-8 receptor antagonists The present invention involves certain 8-ureido and 8-thioureido, 1,2-benzothiazines, 1,2,4-benzothioxazines and 1,2,4-benzothiodiazines useful in the treatment of disease states mediated by the chemokine, Interleukin-8.... | 08/20/2002 |
| 6329366 | Pharmaceutical compounds A pharmaceutical compound of the formula ##STR1## in which R1 and R2 are each hydrogen, halo, cyano or methyl, the dotted line represents an optional double bond, ##STR2## where R4 and R5 are each hydrogen, C1-6... | 12/11/2001 |
| 6316413 | Peptide agonists of bradykinin B2 receptor The invention concerns a pseudopeptide compounds selected among the set constituted by: (i) the compounds of formula (I): ##STR1## in which: A1 represents a single bond, D-Arg or L-Lys; A2 represents L-Pro or trans-4-hydroxy-L-Pro (4Hyp);... | 11/13/2001 |
| 6265399 | Certain benzothiazine dioxide endothelin antagonists and processes for their preparation The instant invention is a series of benzothiazine dioxides, or a pharmaceutically acceptable salt thereof, which are potent endothelin A antagonists with profound in vitro activity, and improved syntheses for the Formula 1 ##STR1## The compounds are... | 07/24/2001 |
| 6252070 | Certain benzothiazine dioxide endothelin antagonists and processes for their preparation The instant invention is a series of benzothiazine dioxides, or a pharmaceutically acceptable salt thereof, which are potent endothelin A antagonists with profound in vitro activity, and improved syntheses for the Formula 1 ##STR1## The compounds are... | 06/26/2001 |
| 6242207 | Diagnostic compositions and devices utilizing same A dry chemistry reagent matrix composition is provided containing a matrix material and a reagent composition containing 3-methyl-6(sulfonate salt)-benzothiazolinone-(2)-hydrazone (MBTH-S), N-ethyl-N-(3-sulfopropyl)aniline, and an oxidase enzyme or a pero... | 06/05/2001 |
| 6083515 | Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group and (ii) a compound that d... | 07/04/2000 |
| 6069114 | 2-amino-4-bicycloamino-1,3,5-Triazines, their preparation, and their use as herbicide and plant growth regulators Compounds of the formula (I) and their salts ##STR1## in which R1 to R6, Y1, to Y2, Y3, m and n are as defined in claim 1 are suitable as herbicides and plant growth regulators. They can be prepa... | 05/30/2000 |
| 6048858 | Compositions and methods to prevent toxicity induced by nonsteroidal antiflammatory drugs Nonsteroidal antiinflammatory drugs which have been substituted with a nitrogen monoxide group; compositions comprising (i) a nonsteroidal antiinflammatory drug, which can optionally be substituted with a nitrogen monoxide group and (ii) a compound that d... | 04/11/2000 |
| 6040151 | Diagnostic compositions and devices utilizing same A dry chemistry dye indicator composition provides improved shelf life, stable color indication end point and capability for a system at near normal pH. The novel dry chemistry dye indication system comprises 3-Methyl-6-(sodium sulfonate)-benzothiazolinon... | 03/21/2000 |
| 5874429 | Benzothiazine derivative Disclosed are benzothiazine derivatives represented by the following formula (I): ##STR1## The benzothiazine derivatives (I) and their salts according to the present invention have strong serotonin-2 blocking action, have excellent selectivity t... | 02/23/1999 |
| 5856503 | Aminoalkyl-substituted benzo-heterocyclic compounds Aminoalkyl-substituted benzo-heterocyclic compounds of the formula ##STR1## wherein M, Q, R and T are as defined in the specification, as well as acid addition salts thereof. These compounds are useful as cholesterol level lowering agents and as anti... | 01/05/1999 |
| 5776719 | Diagnostic compositions and devices utilizing same A dry chemistry dye indicator composition provides improved shelf life, stable color indication end point and capability for a system at near normal pH. The novel dry chemistry dye indication system comprises 3-Methyl-6-(sodium sulfonate)-benzothiazolinon... | 07/07/1998 |
| 5773437 | Alkylenediamine derivatives The present invention relates to alkylenediamine derivatives which relieve urinating contraction and therefore are of value as active ingredients of therapeutic agents for treating dysuria.... | 06/30/1998 |
